Insulin Delivery Devices Market Size, Share & Forecast Report, 2034 

Insulin Delivery Devices Market - By Product, By End Use - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Product trends

2.2.3&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.1.1&nbsp;&nbsp;&nbsp; Supplier landscape

3.1.2&nbsp;&nbsp;&nbsp; Factors affecting the value chain

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising prevalence of diabetes

3.2.1.2&nbsp;&nbsp;&nbsp; Technological advancements in insulin delivery devices

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing diabetes care expenditure

3.2.1.4&nbsp;&nbsp;&nbsp; Favourable device insurance and reimbursement policies

3.2.1.5&nbsp;&nbsp;&nbsp; Adoption of facilitative initiatives

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of insulin delivery devices

3.2.2.2&nbsp;&nbsp;&nbsp; High out-of-pocket expenditure in developing countries

3.2.2.3&nbsp;&nbsp;&nbsp; Stringent government regulations

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.4&nbsp;&nbsp;&nbsp; Integration with digital health platforms

3.2.5&nbsp;&nbsp;&nbsp; Development of smart and wearable devices

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.4.4&nbsp;&nbsp;&nbsp; Latin America

3.4.5&nbsp;&nbsp;&nbsp; Middle East and Africa

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.5.1&nbsp;&nbsp;&nbsp; Current technological trends

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.8&nbsp;&nbsp;&nbsp; Patent analysis

3.9&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.10&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.11&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.2.1&nbsp;&nbsp;&nbsp; Global

4.2.2&nbsp;&nbsp;&nbsp; North America

4.2.3&nbsp;&nbsp;&nbsp; Europe

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Merger and acquisition

4.6.2&nbsp;&nbsp;&nbsp; Partnership and collaboration

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 &ndash; 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Insulin delivery devices

5.2.1&nbsp;&nbsp;&nbsp; Insulin pumps

5.2.1.1&nbsp;&nbsp;&nbsp; Tubed pumps

5.2.1.2&nbsp;&nbsp;&nbsp; Tubeless pumps

5.2.2&nbsp;&nbsp;&nbsp; Pens

5.2.2.1&nbsp;&nbsp;&nbsp; Reusable

5.2.2.2&nbsp;&nbsp;&nbsp; Disposable

5.2.3&nbsp;&nbsp;&nbsp; Other insulin delivery devices

5.3&nbsp;&nbsp;&nbsp; Consumables

5.3.1&nbsp;&nbsp;&nbsp; Testing strips

5.3.2&nbsp;&nbsp;&nbsp; Pen needles

5.3.2.1&nbsp;&nbsp;&nbsp; Standard

5.3.2.2&nbsp;&nbsp;&nbsp; Safety

5.3.3&nbsp;&nbsp;&nbsp; Syringes

5.3.4&nbsp;&nbsp;&nbsp; Insulin pumps consumables

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 &ndash; 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Hospitals and Clinics

6.3&nbsp;&nbsp;&nbsp; Home care

6.4&nbsp;&nbsp;&nbsp; Other end users

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Spain

7.3.5&nbsp;&nbsp;&nbsp; Italy

7.3.6&nbsp;&nbsp;&nbsp; Netherlands

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; India

7.4.3&nbsp;&nbsp;&nbsp; Japan

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.6&nbsp;&nbsp;&nbsp; Middle East and Africa

7.6.1&nbsp;&nbsp;&nbsp; South Africa

7.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; B. Braun Melsungen AG

8.2&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

8.3&nbsp;&nbsp;&nbsp; Biocon

8.4&nbsp;&nbsp;&nbsp; Debiotech S.A.

8.5&nbsp;&nbsp;&nbsp; Dongbao Pharmaceutical

8.6&nbsp;&nbsp;&nbsp; Eli Lilly &amp; Company

8.7&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd.

8.8&nbsp;&nbsp;&nbsp; Gan &amp; Lee Pharmaceuticals

8.9&nbsp;&nbsp;&nbsp; Haselmeier

8.10&nbsp;&nbsp;&nbsp; Insulet Corporation

8.11&nbsp;&nbsp;&nbsp; Julphar

8.12&nbsp;&nbsp;&nbsp; Lenomed Medical

8.13&nbsp;&nbsp;&nbsp; Medtronic plc

8.14&nbsp;&nbsp;&nbsp; MicroPort

8.15&nbsp;&nbsp;&nbsp; Nipro Corporation

8.16&nbsp;&nbsp;&nbsp; Novo Nordisk

8.17&nbsp;&nbsp;&nbsp; Owen Mumford

8.18&nbsp;&nbsp;&nbsp; Sanofi

8.19&nbsp;&nbsp;&nbsp; Scientific Corporation

8.20&nbsp;&nbsp;&nbsp; Suzhou Peng Ye Medical Devices

8.21&nbsp;&nbsp;&nbsp; Tandem Diabetes Care

8.22&nbsp;&nbsp;&nbsp; Terumo Corporation

8.23&nbsp;&nbsp;&nbsp; ViCentra B.V.

8.24&nbsp;&nbsp;&nbsp; Wockhardt Ltd.

8.25&nbsp;&nbsp;&nbsp; Ypsomed Holdings

&nbsp;&nbsp;&nbsp;

Insulin Delivery Devices Market

Get a free sample of this report